Growth capital for the life sciences

analytica 2020 – new date

analytica 2020 will take place from October 19 – 22, 2020.
All tickets purchased and vouchers redeemed remain valid for the upcoming event.

Which funding options are available to start-ups as well as to small- and medium-sized enterprises? The search for investors is often not easy for young life sciences companies. A deep insight into the current challenges and solutions will be provided by the analytica Finance Day, organized by Going Public Media, which will be taken place again at analytica Biotech Forum.

Financing opportunities for the life sciences

The Finance Day has been devoting itself to the start-up, growth and capital market financing of life science companies for 14 years.

At the Finance Day, company representatives will be reporting on the options they have used on their growth path. They will be providing practical insights into the issues concerned, thus giving visitors ideas for their own corporate financing.

Program Finance Days 2020

14:30 Uhr – Opening and Introduction „Finance Days“
Moderation: Benjamin Heimlich, Chefredakteur VentureCapital Magazin (Englisch)

14:35 – 15:00 – Keynote: Fundraising Lessons Learned
Marc Filerman, Chief Executive Officer, German Life Science Accelerator (Englisch)

10:05 – 10:30 Uhr – Impuls „Vom Start-Up zum Global Player“ (German)
Dr. Sierk Poetting, Chief Financial Officer und Chief Operating Officer, BioNtech und Michael Motschmann, Executive Board, MIG Verwaltungs AG im Gespräch mit Mathias Renz, Relationship Manager GoingPublic Media

10:30 – 11:30 Uhr – Panel 1: Venture Capital & Co.: Aktuelle Finanzierungstrends in der Biotechnologie (German)
Moderation: Holger Garbs, Redakteur, Plattform Life Sciences

  • Andreas Huber, Senior Investment Manager, Bayern Kapital
  • Dr. Aristoteles Nastos, Head of Venture Capital Life Science & Cleantech, NRW BANK & CEO Gründerfonds Ruhr
  • Dr. Bernhard Noreisch, Rechtsanwalt und Partner, Lutz Abel PartG mbB
  • Dr. Sebastian Pünzeler, Investment Manager (Life Sciences), coparion
  • Marco Winzer, Partner, High-Tech Gründerfonds

12:00 –13:00 Uhr – Panel 2: Pharma and Biotech: New finance models for former Life Science Companies
Moderation: Dr. Hubert Birner, Managing Partner TVM Life Science Management

  • Michael Salzmann, Chief Executive Officer, AL-S Pharma
  • Enno Spillner, Chief Financial Officer, Evotec AG

14:30 – 15:30 Uhr – Panel 3: Stock exchange and IPO: „IPO – a piece of cake?”
Moderation: Thomas Strassner, Partner, Dentons Europe LLP

  • Sebastian Grabert, Director – Germany Representative, EURONEXT
  • Adam Kostyál, Senior Vice President, Nasdaq Stockholm
  • Dieter Lingelbach, Managing Director, SIRION Biotech
  • Frans-Matthis Pleie, Director, Bryan-Garnier
  • Richard Stoffelen, Chief Financial Officer, Centogene

16:00 – 17:00 Uhr – Panel 4: China – Opportunities and challenges for Life Sciences Companies

  • Dr. Albrecht Läufer, Chief Executive Officer, BluCon Biotech
  • Dr. Kai Lamottke, Managing Director, Bicoll
  • Dr. Ernst Ludes, Managing Director, CV Capital
  • Rafael Ratzel, Executive Director, Head of International Business Department, Tsinghua Capital Holdings
  • Dr. Jan zur Hausen, Partner, EC Healthcare Fund

Ab ca. 17:00 Uhr – Networking Reception Finance Days – Drinks & Snacks

10:05 – 10:35 Uhr – Keynote: Neue Methoden in der Humangenetik – der Weg zur Präzisionsmedizin (German)
Dr. Dr. Saskia Biskup, Chief Executive Officer, CeGaT und Praxis für Humangenetik, Tübingen

10:35 –11:35 Uhr Panel 1: „Von der Diagnostik zur zielgerichteten Therapie – Was ist in der individualisierten Medizin bereits möglich?“ (German)
Moderation: Dr. Pablo Serrano, Geschäftsfeldleiter Innovation & Forschung/Biotechnologie, Bundesverband der Pharmazeutischen Industrie e.V.

  • Dr. Christian Meisel, Chief Medical Officer, Molecular Health
  • Nicolas Schauer, Co- Chief Executive Officer and Chief Security Officer, Biocrates
  • Steffen Schuster, Chief Executive Officer, ITM Isotopen Technologien

11:35 – 12:05 Uhr – Vortrag 1: KI in der Leukämiediagnostik: Wie sieht die Diagnostik der Zukunft aus? (German)
Prof. Dr. Dr. Torsten Haferlach, , Chief Executive Officer, MLL Münchner Leukämielabor

14:30 – 15:00 Uhr – analytica Start-up Award Ceremony / Resüme

Organizer Finance Day

Trade fair
Buy tickets and redeem vouchers

Purchase your analytica ticket quickly and easily online. You will benefit from reduced advance sale prices and will avoid waiting time at the...

Tickets & Prices
Good reasons to attend

analytica is World's Leading Trade Fair. It is the only exhibition that gives you a comprehensive market overview with unique breadth and depth.

Good reasons to attend
Supporting program
The analytica supporting programme

Get an overview of all events planned at analytica: From live demonstrations to forums and Focus Days.

Supporting programm